What's New in Breast Cancer - Susan G. Komen®
Learn about new breast cancer treatment breakthroughs and recent developments in research that are fueling new ways to assess risk, prevent, detect and diagnose breast cancer.
Estrogen a more powerful breast cancer culprit than we realized
May 17, 2023 · The findings suggest that estrogen-suppressing drugs such as tamoxifen — often given to patients with breast cancer to prevent disease recurrence — work in a more direct manner than simply reducing breast cell proliferation.
Breast Cancer News -- ScienceDaily
Dec 12, 2024 · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
Breast Cancer Research News
Dec 19, 2024 · Find out what the latest clinical trial results mean for you. Imlunestrant Plus Verzenio: New Treatment Option for Certain Hormonal Therapy-Resistant Breast Cancers? Combined with Verzenio, this new oral SERD may be a good option for advanced-stage breast cancer with an ESR1 mutation. Dec 19, 2024 | Hormonal Therapy.
Breast cancer deaths in the US continue to fall, but new report …
Oct 1, 2024 · The study, published Tuesday in CA: A Cancer Journal for Clinicians, found some good news: The overall breast cancer death rate in the US dropped about 44% between 1989 and 2022, which...
New study finds triple-negative breast cancer tumors with an …
Apr 25, 2024 · People with early-stage triple-negative breast cancer and high levels of immune cells in their tumors may have a lower risk of recurrence and better survival rates.
Breast cancer - Latest research and news | Nature
Dec 20, 2024 · Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium). Breast...
Breast cancer metastasis on/off switch revealed - Stanford News
New research from Stanford and the Arc Institute could lead to a new and more effective immunotherapy and help clinicians better predict patient response to existing medicines. Songnan Wang (left) and Lingyin Li (right) found that a protein called ENPP1 acts as an on/off switch for breast cancer metastases.
FDA expands approval of breast cancer drug Kisqali to ... - NBC News
Sep 17, 2024 · In a phase 3 clinical trial from the drugmaker Novartis, Kisqali reduced the risk of a patient’s breast cancer coming back by 25% after three years when given in addition to standard...
Breast Cancer News
Our coverage of trending topics in breast cancer medicine, treatment, and screening, plus the latest on living with breast cancer.
- Some results have been removed